It is reported that the ROS in patients with COVID-19 increases [34], so the level of copper ions in patients with COVID-19 is unbalanced, thus inducing cuprotosis, and further regulating oxidative stress through the FDX1-LAS axis, leading to the increase of ROS in the body. This evidence concerns the gene FDX1 and COVID-19.